According to GuruFocus Insider Data, the recent CFO buys were: ION Geophysical Corp. (IO, Financial), Harvard Apparatus Regenerative Technology Inc. (HART, Financial) and Flotek Industries Inc. (FTK, Financial).
ION Geophysical: EVP and CFO Steven Bate bought 200,000 shares
On Nov. 17, EVP and CFO Steven Bate bought 200,000 shares at the average price of 32 cents per share. ION Geophysical has a market cap of $95.595 million and its shares were traded at around 58 cents. The company has a P/S ratio of 0.34.
ION Geophysical announced its 2015 third-quarter results with revenues of $66.67 million and gross profit of $11.12 million; the net loss was $20.38 million. The 2014 total revenue was $509.56 million, a 7% decrease from the 2013 total revenue. The 2014 gross profit was $62.22 million, a 61% decrease from the 2013 gross profit. The 2014 net loss was $128.25 million.
On Nov. 20, Director James M. Lapeyre Jr. bought 389,300 shares at the average price of 47 cents per share. On Nov. 19, Director Franklin Myers bought 100,000 shares at the average price of 41 cents per share. On Nov. 19, Director and Senior Officer George Marius Moen, bought 2,000 shares at the average price of 12 cents per share.
Harvard Apparatus Regenerative Technology: CFO Thomas Mcnaughton bought 35,000 shares
On Nov. 19, CFO Thomas Mcnaughton bought 10,000 shares at an average price of $1.70 per share. The price of the stock has increased by 29.41%. Harvard Apparatus Regenerative Technology has a market cap of $29.595 million and its shares were traded at around $2.20. The company has a P/S ratio of 138.54.
Harvard Apparatus Regenerative Technology announced its 2015 second-quarter results with revenues of $73,000 and gross profit of $36,000; the net loss was $4.5 million. The 2014 total revenue was $93,000, a 323% increase from the 2013 total revenue. The 2014 gross profit was $45,000, a 309% increase from the 2013 gross profit. The 2014 net loss was $11.06 million.
On Nov. 19, President and CEO James Joseph Mcgorry bought 10,000 shares at an average price of $1.79. The price of the stock has increased by 22.91%. On Nov. 17, Director David Green bought 25,000 shares at an average price of $1.34. The price of the stock has increased by 64.18%. On Sept. 18, Chief Medical Officer Saverio Lafrancesca bought 9,500 shares at an average price of $1.29. The price of the stock has increased by 70.54%.
Flotek Industries: CFO Robert M. Schmitz bought 12,200 shares
On Nov. 17, CFO Robert M. Schmitz bought 12,200 shares at an average price of $9.76. The price of the stock has increased by 16.29%. Flotek Industries Inc. has a market cap of $608.671 million and its shares were traded at around $11.35. The company has a P/E ratio of 155.47 and P/S ratio of 1.63.
Flotek Industries announced its 2015 third-quarter results with revenues of $87.94 million and gross profit of $31.23 million; the net income was $1.98 million. The 2014 total revenue was $449.16 million, a 21% increase from the 2013 total revenue. The 2014 gross profit was $182.96 million, a 24% increase from the 2013 gross profit. The 2014 net income was $53.60 million.
On Aug. 10, Chairman, President and CEO John Chisholm sold 112,000 shares at an average price of $18.47. The price of the stock has decreased by 38.55%. On Nov. 4, Director John Reiland sold 4,380 shares at an average price of $19.21. The price of the stock has decreased by 40.92%. On Oct. 5, EVP Chemistry Research Joshua A. Snively sold 30,000 shares at an average price of $17.77. The price of the stock has decreased by 36.13%.
